A transdermal drug delivery system and its controlled release disc

By introducing a heating unit and an identification and authentication unit into the controlled-release plate, the problem of the controlled-release plate being stolen or misconnected is solved, safe temperature control and monitoring are achieved, and the safety of the transdermal drug delivery system is improved.

CN122399221APending Publication Date: 2026-07-17HUAXIA CHENGHUANG (BEIJING) HEALTH TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HUAXIA CHENGHUANG (BEIJING) HEALTH TECH CO LTD
Filing Date
2026-05-09
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

In existing transdermal drug delivery systems, the controlled-release disc lacks effective identification, and non-dedicated general-purpose control components and power adapters can directly drive heating, posing safety hazards. This can lead to theft or misconnection of the controlled-release disc, and it is impossible to achieve effective temperature control and safety monitoring.

Method used

A heating unit and an identification and authentication unit are introduced into the controlled-release plate. The identification and authentication unit controls the on/off state of the heating unit to ensure that the heating circuit is formed only under authorized devices, preventing unauthorized devices from driving the heating.

Benefits of technology

This enhances the safety of the controlled-release disc, preventing theft or misconnection, ensuring the safety of temperature control, and avoiding medical risks such as overheating of the skin or low-temperature burns.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122399221A_ABST
    Figure CN122399221A_ABST
Patent Text Reader

Abstract

The present disclosure provides a transdermal drug delivery system and a controlled release disc thereof, and relates to the technical field of medical devices, wherein the controlled release disc comprises a heating unit and an identification authentication unit, a first end of the heating unit is electrically connected with a first power signal end, and a second end is in communication or disconnected with a common voltage signal end based on the state of the identification authentication unit; the identification authentication unit is electrically connected between the second end of the heating unit and the common voltage signal end, and is also electrically connected with a second power signal end and a first control signal receiving end; the identification authentication unit is at least configured to adjust the communication state of the second end of the heating unit and the common voltage signal end in response to a first control signal transmitted by the first control signal receiving end. According to the signal received by the first control signal receiving end, the present disclosure adjusts the state of the identification authentication unit and controls the on-off state of the heating circuit, so that the present disclosure is conducive to preventing the controlled release disc from being misused or misconnected, thereby improving the safety of the transdermal drug delivery system.
Need to check novelty before this filing date? Find Prior Art